Multimodal Markers of Neurodegenerative Disorders at Presymptomatic Stages
NCT06516016 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000
Last updated 2024-07-23
Summary
NeuroPrems is a prospective, monocentric, longitudinal, not relating to a medicinal product for human use, non-randomized, non-controlled research. The study mainly aims to identify longitudinal changes and events in multimodal markers of neurodegeneration and neuroinflammation during the presymptomatic phases of neurodegenerative diseases.
Conditions
Interventions
- RADIATION
-
PET
\[18F\]DPA-714 will be injected intravenously as a 1 minute intravenous bolus injection and dynamic PET acquisition will last 90 min. The aim is the quantification of the neuroimmune reaction during neuroinflammation process.
- OTHER
-
MRI 3T
Brain MRI will aim at providing imaging biomarkers which will allow evaluating brain structure, microstructure, iron load, myelin, neurodegeneration of the substantia nigra and locus coeruleus, functional connectivity, brain perfusion and the glymphatic system.
- OTHER
-
Oculomotricity assessment
Recording eye movements in a controlled environment (requiring no specific room or area) in binocular vision at a frequency \> 500Hz, while retaining infrared video footage of eye movements for high-quality clinical monitoring.
- OTHER
-
Magnetoencephalography assessment
Recording brain magnetic activity using the Elekta Neuromag® TRIUX Magnetoencephalograph ; The participant will be comfortably seated in an adjustable-height chair. The device is enclosed in a shielded room isolated from external electric and magnetic fields to measure the extremely weak magnetic activities produced by the brain.
- OTHER
-
Body posture and gait assessment
The acquisition of kinematic gait parameters will be achieved ; markers are positioned on the different segments of members, recognized by a camera system positioned on the walls. Neurophysiologic muscular activity of the lower limbs will also be recorded.
- OTHER
-
Voice recording
Participants will be recorded during a single session at every visit upon baseline with a professional quality head mounted microphone.
- OTHER
-
Video-polysomnography
Participants will complete standard sleep questionnaires before the visit and perform neurophysiological tests including cognitive tasks before and after the sleep recording.
- BIOLOGICAL
-
Blood sampling, skin biopsy, excreta sampling, lumbar puncture
Experimental analyses, genetic and multi-OMIC analyses for biomarker research.
Sponsors & Collaborators
-
Paris Brain Institute (ICM)
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 95 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-09-01
- Primary Completion
- 2034-08-31
- Completion
- 2034-08-31
Countries
- France
Study Locations
More Related Trials
-
Multi-modal Neuroimaging in Alzheimer's Disease
NCT01554202 ·Status: UNKNOWN ·Phase: NA
-
Exploring the Gut-Brain Axis in Ageing and Neurodegeneration
NCT05934188 ·Status: RECRUITING
-
The GBA Multimodal Study in Parkinson's Disease
NCT04101968 ·Status: RECRUITING
-
The Relationship Between Neuropsychological Testing and MRI, PET and COBRE - Project 1: AIM 2 (GE-180)
NCT03702816 ·Status: TERMINATED ·Phase: PHASE2
-
Study on Multimodal Imaging and Molecular Imaging Techniques in Degenerative Dementia
NCT06534658 ·Status: RECRUITING
-
Multimodal Ocular Imaging in Neurodegeneration
NCT03699644 ·Status: COMPLETED
-
Intelligent Digital Tools for Screening of Brain Connectivity and Dementia Risk Estimation in People Affected by Mild Cognitive Impairment
NCT05159661 ·Status: RECRUITING
-
Explore Biomarkers of Motor Neuron Disease/Frontal Dementia Spectrum Disease in China
NCT04961450 ·Status: ENROLLING_BY_INVITATION
-
Positron Emission Tomography of Amyloid in Alzheimer's Disease
NCT00205621 ·Status: SUSPENDED ·Phase: PHASE1
-
Multi-modality MRI Study on Prediction for Mild Cognitive Impairment Conversion
NCT02353884 ·Status: COMPLETED
-
Multi-modality MRI Study on Differences in Conversion of aMCI Patients With APOEε4 to AD
NCT02225964 ·Status: COMPLETED
-
BOLD Functional Magnetic Resonance Imaging (fMRI) and Cerebral Blood Flow Measurements as Biomarkers for Cognition Enhancing Drugs (3134-006)
NCT00887601 ·Status: COMPLETED ·Phase: PHASE1
-
A Prospective Longitudinal Study in Adults With Multifocal Motor Neuropathy
NCT05988073 ·Status: ACTIVE_NOT_RECRUITING
-
Ultra High Field Magnetic Resonance Imaging as a Biomarker for Premotor Parkinson's Disease
NCT03288909 ·Status: UNKNOWN
-
Imaging Blood Brain Imaging Dysfunction in Parkinson's Disease
NCT02605161 ·Status: COMPLETED
-
Clinical Applicantion of Multi-Tracer PET/MR Imaging in Neurological Disorders/Disease
NCT06092125 ·Status: RECRUITING
-
PET Imaging of the Translocator Proteine Ligands (TSPO) With [18 F] DPA-714 Biomarker of NeuroInflammation in Cognitive Decline (NIDECO)
NCT02062099 ·Status: COMPLETED ·Phase: PHASE1
-
Longitudinal Assessment of Protein Markers in the Cerebrospinal Fluid of Patients With Central Nervous System Involvement
NCT07313098 ·Status: NOT_YET_RECRUITING
-
PET Brain Imaging in Multiple Sclerosis, Alzheimer's Disease, and Other Neurological and Neuropsychiatric Diseases
NCT02649985 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Activity of Cerebral Networks, Amyloid and Microglia in Aging and Alzheimer's Disease
NCT06224920 ·Status: COMPLETED
-
Early Longitudinal Imaging in the Parkinson's Progressive Marker Initiative (PPMI) Using (18F)AV-133 (PPMI AV-133 Prodromal Imaging)
NCT07265596 ·Status: RECRUITING ·Phase: PHASE2
-
Cognitive Function and Prevalence of Amyloid Marker in Frail Older Adults
NCT03129269 ·Status: COMPLETED ·Phase: NA
-
Predict to Prevent PGRN Disease
NCT06711510 ·Status: WITHDRAWN ·Phase: NA
-
Establishment of the Chinese Preclinical Alzheimer's Disease Study With Multiple Neuroimaging
NCT06827678 ·Status: RECRUITING
-
Evaluation of [18F] PBR06 and PET as a Marker of Inflammation in Subjects With Neurological Conditions
NCT01028209 ·Status: TERMINATED ·Phase: PHASE1